IMR Press / CEOG / Volume 32 / Issue 1 / pii/2005018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Retraction published on 15 December 2020, see Clinical and Experimental Obstetrics & Gynecology 2020, 47(6)
Open Access Original Research

Artificial fetal lung maturation - Prevention of antenatal complications in premature deliveries

Show Less
1 Institute of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade (Serbia and Montenegro)
Clin. Exp. Obstet. Gynecol. 2005, 32(1), 61–64;
Published: 10 March 2005
Abstract

Keeping in mind the frequency of pretern deliveries as well as the morbidity and mortality of the newborn population, many ways of bringing about faster maturation of the fetus have been. Today, we can say that after the 24th week of gestation, when the pneumocites time 2 are anatomically formatted, medical treatment of the fetus for maturation not only of the lungs but all the vulnerable organs is available. By stimulating the pneumocites to make surfactant and sphingomyeline and phosphatidilinositol and phosphatidilglycerol, we can reduce respiratory distress syndrome. Moreover, the frequency of intracranial haemorage is lowered. We have performed many studies with all of their positive and negative effects, including: use of corticosteroids, thyroxine, aminophilline, surfactant, inositole and beta adrenergic agonist.

Keywords
Artificial fetus maturation
Corticosteroids
Thyroxine
Aminophilline
Surfactant
Inositole
Beta-adrenergic agonist
Share
Back to top